Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis

被引：2
作者：
Goeijenbier, M. [1 ]
van Kampen, J. J. A. [1 ]
Reusken, C. B. E. M. [1 ]
Koopmans, M. P. G. [1 ,2 ]
van Gorp, E. C. M. [1 ]
机构：
[1] Erasmus MC, Dept Virosci, Rotterdam, Netherlands
[2] Natl Inst Publ Hlth & Environm RIVM Netherlands, Natl Coordinat Ctr Communicable Dis Control CIb, Bilthoven, Netherlands
来源：
NETHERLANDS JOURNAL OF MEDICINE | 2014年 / 72卷 / 09期
关键词：
Ebola virus disease; viral haemorrhagic fever; filovirus; pathogenesis; treatment; VIRAL HEMORRHAGIC FEVERS; ANTIBODY-DEPENDENT ENHANCEMENT; NONHUMAN-PRIMATES; POSTEXPOSURE PROTECTION; WEST-AFRICA; T-705; FAVIPIRAVIR; INFECTED PATIENTS; RNA INTERFERENCE; GUINEA-PIGS; MARBURG;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Currently, West Africa is facing the largest outbreak of Ebola virus disease (EVD) in history. The virus causing this outbreak, the Zaire Ebolavirus (EBOV), belongs to the genus Ebolavirus which together with the genus Marburgvirus forms the family of the Filoviridae. EBOV is one of the most virulent pathogens among the viral haemorrhagic fevers, and case fatality rates up to 90% have been reported. Mortality is the result of multi-organ failure and severe bleeding complications. By 18 September 2014, the WHO reported of 5335 cases (confirmed, suspected and probable) with 2622 deaths, resulting in a case fatality rate of around 50%. This review aims to provide an overview of EVD for clinicians, with the emphasis on pathogenesis, clinical manifestations, and treatment options.
引用
收藏
页码：442 / 448
页数：7
相关论文
共 50 条
  • [41] Pulmonary Involvement during the Ebola Virus Disease
    Lalle, Eleonora
    Biava, Mirella
    Nicastri, Emanuele
    Colavita, Francesca
    Di Caro, Antonino
    Vairo, Francesco
    Lanini, Simone
    Castilletti, Concetta
    Langer, Martin
    Zumla, Alimuddin
    Kobinger, Gary
    Capobianchi, Maria R.
    Ippolito, Giuseppe
    VIRUSES-BASEL, 2019, 11 (09):
  • [42] Ebola virus disease: Biology, diagnosis, treatment and prevention of epidemics
    Kumar S.
    Kumari R.
    Pandey R.
    Sharma V.
    Proceedings of the Indian National Science Academy, 2017, 83 (01): : 103 - 149
  • [43] Clinical Presentation and Care of Patients with Ebola Virus Disease in the China Ebola Treatment Unit, Liberia
    Shao, Xiaoping
    Ren, Weizheng
    Zhou, Feihu
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2017, 70 (01) : 32 - 37
  • [44] Antiviral therapeutics for the treatment of Ebola virus infection
    Cardile, Anthony P.
    Downey, Lydia G.
    Wiseman, Perry D.
    Warren, Travis K.
    Bavari, Sina
    CURRENT OPINION IN PHARMACOLOGY, 2016, 30 : 138 - 143
  • [45] An overview of Ebola virus disease
    Kadanali, Ayten
    Karagoz, Gul
    NORTHERN CLINICS OF ISTANBUL, 2015, 2 (01) : 81 - 86
  • [46] Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease
    Schafer, Adam
    Cheng, Han
    Lee, Charles
    Du, Ruikun
    Han, Julianna
    Perez, Jasmine
    Peet, Norton
    Manicassamy, Balaji
    Rong, Lijun
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (38) : 5177 - 5190
  • [47] Treatment of Ebola Virus Disease: From Serotherapy to the Use of Monoclonal Antibodies
    Shcherbakov, Dmitriy N.
    Isaeva, Anastasiya A.
    Mustaev, Egor A.
    ANTIBODIES, 2025, 14 (01)
  • [48] Small-Molecule Therapeutics for Ebola Virus (EBOV) Disease Treatment
    Izawa, Kunisuke
    Luis Acena, Jose
    Wang, Jiang
    Soloshonok, Vadim A.
    Liu, Hong
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2016, 2016 (01) : 8 - 16
  • [49] Recent advances in the development of vaccines for Ebola virus disease
    Ohimain, Elijah Ige
    VIRUS RESEARCH, 2016, 211 : 174 - 185
  • [50] A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment
    Schuler, James
    Hudson, Matthew L.
    Schwartz, Diane
    Samudrala, Ram
    MOLECULES, 2017, 22 (10):
12345